Deal Ends TodayยทSave 35% annual plan
Inhaled COPD therapyReviewed for 2026 plan year

Does Anthem Cover Trelegy?

The verdict

Covered on most plans

Anthem covers Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) as a brand maintenance inhaler across commercial, Medicare Advantage, and Medicaid lines through CarelonRx. Because Trelegy is brand-only with no generic, there is no generic-substitution question โ€” but some Anthem plans apply prior authorization or step therapy requiring documentation of a simpler inhaler tried first. Verify PA and step-therapy requirements on the specific Anthem plan formulary.

MedicareCovered
CommercialCovered
See the difference

Coverage is set by your specific plan and formulary. This is a research summary โ€” always confirm with Anthem using your member ID.

Reviewed for 2026
Checked against the active plan year
Sourced from formularies
Anthem drug lists + CMS guidance
Updated as rules change
Coverage and prior-auth criteria shift often
Verify before you decide
Informational only โ€” not insurance advice

Key facts

  • Trelegy Ellipta is a once-daily triple-therapy inhaler (ICS + LABA + LAMA) for COPD and asthma โ€” brand-only, no generic approved as of 2026.

    FDA drug labeling, Trelegy Ellipta

  • The 2026 Medicare Part D beneficiary out-of-pocket cap is $2,100, limiting annual exposure for Medicare Advantage enrollees with Trelegy on formulary.

    CMS, Medicare Part D 2026 Changes

  • Anthem operates its pharmacy benefit through CarelonRx (formerly IngenioRx); step-therapy and PA requirements are administered via CarelonRx.

    Anthem/Elevance Health, CarelonRx formulary policies

Plan types

Medicare vs. commercial coverage

Whether Anthem covers Trelegy depends heavily on which kind of plan you hold. They follow completely different rules โ€” here's each one, side by side.

Medicare

Part D & Advantage plans

Covered

Medicare Advantage plans administered by Anthem cover Trelegy for COPD and asthma as a brand maintenance inhaler. Cost-share depends on the plan tier assignment; the 2026 Medicare Part D $2,100 out-of-pocket cap limits total annual exposure. No generic exists, so there is no generic-substitution tier edit. Some Anthem MA plans may apply prior authorization or step therapy requiring trial of a single- or dual-agent inhaler first. Verify on the specific Anthem Medicare Advantage plan formulary or call Anthem member services.

Commercial / Employer

Group & marketplace plans

Covered

Anthem commercial/employer plans cover Trelegy Ellipta as a brand maintenance inhaler through CarelonRx, subject to plan tier and possible prior authorization or step therapy. ACA/individual plans also cover Trelegy where offered by Anthem, at the brand tier with possible step therapy. Medicaid managed-care plans administered by Anthem cover Trelegy per state PDL, with prior authorization and step therapy common for a brand-only triple-therapy inhaler. In all commercial lines, tier placement and UM requirements vary by specific plan โ€” verify on the Anthem drug lookup tool.

Prior authorization

The 3 boxes you must tick to get approved

Commercial plans that will consider Trelegy require prior authorization. Check off what applies to you to see how close you are โ€” this is a guide, not a guarantee of approval.

Requirements you meet0 / 3

Meet all 3 and you have a documented case for approval. Missing any one is the most common reason requests are denied.

What you'll pay

Your cost, three ways

What Trelegy actually costs you swings enormously depending on how it's covered. Here's the realistic range.

No coverage

Paying cash

~$802โ€“$918 per inhaler (30-day supply)

List price with no coverage โ€” before any manufacturer savings card.

PA approved

With coverage

Varies by Anthem plan tier โ€” confirm with your plan's drug lookup. Medicare Advantage cost-share subject to the 2026 $2,100 Part D OOP cap.

Typical monthly copay once prior authorization is approved.

Lowest cost

Bridge program

GSK (Trelegy manufacturer) offers a patient assistance program (myGSK Assistance Program) for eligible uninsured and underinsured patients. Verify eligibility at gsk.com.

Reduced copay through the assistance program, where eligible.

All cost figures are estimates. No generic alternative exists for Trelegy. Actual cost-share depends on plan tier, deductible status, and pharmacy. Verify on the Anthem drug lookup or call Anthem member services.

Do it yourself

Check YOUR exact coverage in 3 steps

General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.

  1. 1

    Use the Anthem drug lookup tool

    Log in to anthem.com, navigate to 'Find a Drug' or 'Formulary,' enter 'Trelegy Ellipta,' and select your specific plan to see tier, PA status, and step-therapy requirements.

  2. 2

    Call Anthem member services

    Call the number on the back of your Anthem ID card and ask specifically: Is Trelegy on my formulary? Is prior authorization or step therapy required? What is my expected cost-share?

  3. 3

    Ask your prescriber to initiate PA if required

    If your Anthem plan requires prior authorization or step-therapy documentation, your prescriber can submit clinical notes confirming COPD or asthma diagnosis and prior inhaler history through CarelonRx's PA process.

If it's denied

Options if Anthem won't cover Trelegy

A denial isn't the end of the road. These are the paths people commonly explore next โ€” discuss any of them with your prescriber.

Anoro Ellipta (umeclidinium/vilanterol)

A dual-agent LABA/LAMA inhaler (no ICS) that may be covered at a lower tier on some Anthem plans; appropriate when ICS is not required.

Breztri Aerosphere (budesonide/glycopyrrolate/formoterol)

Another brand triple-therapy COPD inhaler; tier and UM vary by Anthem plan โ€” may or may not differ from Trelegy on your specific plan.

Advair Diskus / generic fluticasone-salmeterol

ICS/LABA combination inhaler; a generic version is available and may be on a preferred tier; appropriate where a dual agent is clinically sufficient.

These options are listed for information only โ€” your own clinician decides what is appropriate for you.

โ“Frequently Asked Questions

Some Anthem plans via CarelonRx require prior authorization or step therapy before approving Trelegy. The typical requirement is documentation that the patient tried a simpler inhaler first and that triple-combination therapy is clinically appropriate for their COPD or asthma. If your plan requires PA, your prescriber submits the request through CarelonRx. Verify PA requirements on the Anthem drug lookup or call member services, since requirements vary by specific Anthem plan.

No. Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) is brand-only โ€” no FDA-approved generic or biosimilar equivalent is available as of 2026. This means Anthem cannot substitute a generic, and the coverage question is whether the brand inhaler is approved under your plan's tier and UM rules. GSK's patient assistance program may help uninsured or underinsured patients access Trelegy at lower or no cost.

Yes. The 2026 Medicare Part D $2,100 beneficiary out-of-pocket cap applies to covered Part D drugs including Trelegy on Anthem Medicare Advantage plans. Once your OOP spending reaches that cap, you pay $0 for covered Part D drugs for the rest of the year. Cost-share before hitting the cap depends on your plan's tier assignment for Trelegy. Verify on your specific Anthem Medicare Advantage plan's Evidence of Coverage.

Trelegy was selected by CMS for Medicare drug price negotiation, but it is in a later cohort than the first 10 drugs whose negotiated prices took effect in 2026. A government-negotiated price for Trelegy was not in effect as of 2026. Do not rely on a 2026 negotiated price โ€” verify the current effective year against the CMS selected-drug list before assuming any negotiated-price savings.

Without insurance, Trelegy Ellipta typically costs approximately $802โ€“$918 per inhaler for a 30-day supply. Because no generic exists, GoodRx or manufacturer coupons provide limited discount on the brand. GSK's patient assistance program (myGSK Assistance Program) may offer free or reduced-cost Trelegy to eligible uninsured or underinsured patients. Always verify the most current price on GoodRx or the pharmacy before filling.

This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date โ€” always verify current benefits directly with Anthem before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.